Jerevall, P., Ma, X., Li, H., Salunga, R., Kesty, N. C., Erlander, M. G., . . . Stål, O. (2011). Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial. Nature Publishing Group.
Chicago Style CitationJerevall, P-L, et al. Prognostic Utility of HOXB13 : IL17BR and Molecular Grade Index in Early-stage Breast Cancer Patients From the Stockholm Trial. Nature Publishing Group, 2011.
MLA CitationJerevall, P-L, et al. Prognostic Utility of HOXB13 : IL17BR and Molecular Grade Index in Early-stage Breast Cancer Patients From the Stockholm Trial. Nature Publishing Group, 2011.
Warning: These citations may not always be 100% accurate.